Waldencast plc

Waldencast plc

WALDW
Waldencast plcUS flagNASDAQ Capital Market
0.06
USD
+0.01
- -
6.79MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
94
142
- -
218
274
272
- -
Operating Margin (%)
0.56
-1.14
- -
-37.56
-19.55
-23.88
- -
Depreciation Expense
13
14
- -
60
60
59
- -
Net Income, GAAP
-2
-20
- -
-90
-42
-230
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-2.51
-13.74
- -
-41.25
-15.5
-84.44
- -
Working Capital
- -
18
19
45
27
52
-1
LT Debt
- -
103
177
167
150
146
2
Total Equity
- -
39
800
769
730
500
296
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-5.45
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
-5.46

Capital Structure

FRC

in mil. unless spec.
Sep'21
Mar'22
Jun'22
ST Debt
- -
- -
- -
LT Borrowings
- -
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
43
43
43
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'21
Mar'22
Jun'22
Total Current Assets
1
1
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
2
1
Payables & Accruals
- -
2
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-71,303.24%
-31.49%
Free Cash Flow
- -
- -
45.31%
Net Income, GAAP
- -
- -
441.31%
Sales/Revenue/Turnover
- -
- -
-0.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
218
2024
- -
- -
- -
- -
274
2025
- -
- -
- -
- -
272

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Michel Brousset
Full Time Employees
335
Sector
Technology
Industry
Software - Application
Address
10 Bank Street White Plains NY United States of America 10606
IPO Date
May 19, 2021
Business
Waldencast plc operates as a global multi-brand beauty and wellness platform, dedicated to developing, acquiring, accelerating, and scaling conscious, purpose-driven brands. The company's portfolio encompasses a range of offerings across advanced skincare and cosmetics, targeting diverse consumer needs and preferences. Its Obagi Medical segment provides scientifically backed skincare treatments formulated to diminish the visibility of premature aging, photodamage, dark spots, hyperpigmentation, fine lines, and wrinkles, while improving skin tone and texture. This segment has recently expanded into the aesthetic injectables market, with the acquisition of rights to the Saypha® hyaluronic acid gel line and FDA approval for Obagi® saypha® MagIQ™ planned for a 2026 launch. The Milk Makeup segment offers clean, cruelty-free, and vegan cosmetics, including a variety of makeup and skincare products like foundation, blush, and mascaras. Waldencast distributes its products through a comprehensive network that includes dermatologists, plastic surgeons, medical spas, and other professional skincare channels, alongside major retailers such as Sephora and Ulta Beauty, and direct-to-consumer e-commerce platforms. Established in 2021, the company is headquartered in White Plains, New York.